Satya (Nanu) Das, MD, MSCI, pens this piece on what a career in drug development in the biopharmaceutical field may look like.
Satya Das, MD, MSCI
Advertisement
Articles by Satya Das, MD, MSCI
Satya Das, MD, MSCI, discusses the results of a clinical score analysis in patients with neuroendocrine tumors.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
June’s GI Rewind: CRC, Gastric Cancer See Several “Firsts” With FDA Review of Adjuvant IO, Global Approval of BRAF-Targeted and CAR T-Cell Therapies
2
Namodenoson Meets Safety End Point in PDAC, Shows Durable Survival Outcomes Pretreated Subgroup
3
Taking Science from Bench to Bedside to the Block – Introducing Dr. Robert A. Winn
4
SERENA-6 Controversies Push the Breast Cancer Field to Consider the Future Role of ctDNA-Guided Treatment Decisions
5